In: Office of the Privacy Commissioner of Canada Report (12 November 2020). Available at: priv.gc.ca/en/about-the-opc/what-we-do/consultations/completed-consultations/consultation-ai/pol-ai_202011/
In 2002, the requirements imposed by PIPEDA will extend to encompass all personal health information. PIPEDA will ultimately extend to the collection, use, or disclosure of all personal information in the course of any commercial activity within a province in 2004. This change in Canadian law carries significant consequences for the general business practices of American companies that conduct, or may conduct, business with Canadians. It is therefore crucial for lawyers with clients collecting personal data on- and offline to familiarize themselves with its requirements in order to counsel clients effectively about their current and future obligations under this privacy legislation. Toward that end, this Article provides a descriptive review of PIPEDA, paying particular attention to the requirements it imposes on American businesses that collect Canadians' personal information. As a backdrop for discussion of PIPEDA, Section II briefly sketches the protections of consumer privacy currently provided in the United States, the European Union ("E.U."),and Canada (prior to enactment of PIPEDA). Section III provides an in-depth discussion of the history, terms, and enforcement scope of PIPEDA, paying special attention to the implications of its provisions for American businesses. Lastly, Section IV suggests specific business processes that American businesses should adopt to be in compliance with the Act.
The collection of genetic and health information by employers for reasons that are unrelated to the health and safety of workers is an undue infringement of the right to privacy, and consequently should be firmly prohibited by statute. Comprehensive genetic and health information privacy requires the protection of at least three critical elements of the right to privacy--namely choice, secrecy, and confidentiality. While choice and secrecy protect the individual's right to privacy at the collection stage, confidentiality safeguards this right at the point of disclosure. Laws that focus on the inappropriate use of genetic and health information without addressing the act of collecting such information, as is the case with American laws prohibiting genetic discrimination by employers and others, fail adequately to preserve privacy and prevent discrimination. Existing laws that do address the collection of personal information, such as Canada's Personal Information Protection and Electronic Documents Act (PIPEDA), the general and statutory laws of Quebec, and recent Manitoba legislation are insufficiently explicit with respect to the legality of genetic and health information collection by employers.
In: TEM 2013: Proceedings of the Technology & Emerging Media Track - Annual Conference of the Canadian Communication Association (Victoria, June 5-7, 2012)